Top 10 Fastest-Growing Biotech Stocks: UTHR, GENZ, CELG, EXAS, SHP, WX, PRXL, VIVO, VPHM, PPDI

Below are the top 10 fastest-growing Biotechnology stocks, UPDATED TODAY before 4:30 AM ET, based on the average long-term earnings growth rate estimated by Wall Street analysts. Two Chinese companies (SHP, WX) are on the list.

United Therapeutics Corporation (NASDAQ:UTHR) is the 1st fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 70.7%. This number is based on the average estimate of 7 brokerage analysts.

Genzyme Corporation (NASDAQ:GENZ) is the 2nd fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 25.1%. This number is based on the average estimate of 9 brokerage analysts.

Celgene Corporation (NASDAQ:CELG) is the 3rd fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 24.9%. This number is based on the average estimate of 10 brokerage analysts.

EXACT Sciences Corporation (NASDAQ:EXAS) is the 4th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 23.3%. This number is based on the average estimate of 3 brokerage analysts.

ShangPharma Corp (ADR) (NYSE:SHP) is the 5th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 21.2%. This number is based on the average estimate of 4 brokerage analysts.

WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) is the 6th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 19.2%. This number is based on the average estimate of 5 brokerage analysts.

PAREXEL International Corporation (NASDAQ:PRXL) is the 7th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 17.5%. This number is based on the average estimate of 7 brokerage analysts.

Meridian Bioscience, Inc. (NASDAQ:VIVO) is the 8th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 15.8%. This number is based on the average estimate of 5 brokerage analysts.

ViroPharma Incorporated (NASDAQ:VPHM) is the 9th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 15.7%. This number is based on the average estimate of 3 brokerage analysts.

Pharmaceutical Product Development, Inc. (NASDAQ:PPDI) is the 10th fastest-growing stock in this segment of the market. Its long-term annual EPS growth is expected to be 15.2%. This number is based on the average estimate of 9 brokerage analysts.

Top 6 Stocks for February Energy and health care stocks best buys for the month ahead

#1 Anadarko Petroleum Corporation (APC)

Anadarko Petroleum Corporation (NYSE: APC), a major oil and gas exploration and production company, with operations primarily in the United States, the deepwater of the Gulf of Mexico and Algeria, is in a bull market that began in October 2008. Last year was spent retracing a breakdown that occurred in April. But in December, amid rumors that BHP Billiton (NYSE: BHP) had its sights on APC after failing to acquire Potash Corp. (NYSE: POT), the stock broke out on a huge breakaway gap from a major bottom “V.” Breakaway gaps need not be retraced (covered), so APC may have another major move up from it.

The rumors have not been confirmed, but based on the current price, the stock is still worth purchasing as a play on the continuing increase in the price of crude oil. Anadarko’s earnings for Q4 are expected to rise more than fivefold, according to Thomson Reuters. Technically, the breakout has a target of $90-plus. S&P rates APC a “five-star buy” with a target of $140. Buy now for a trade to $100 or for a long-term target of $130-plus. (more)

Leading Indicator for Oil Hits New All-Time High

Due to South Korea’s heavy exposure to China, and overall growth of the Asian market, the Korean KOSPI Index—the Dow Jones for Korea—serves as a very nice leading indicator for the price of crude. As seen below, peaks and troughs in the KOSPI (red) tend to lead the overall price of crude (black) by anywhere from a couple months to a year. As of now, the KOSPI index is hitting new all-time highs with crude playing catch up. With recent events now taking place in Egypt and the safety of a vital chokepoint coming under concern, we may see the current divergence between the two charts narrow quite quickly.

Source: Bloomberg

Also, if we take a look at OPEC production we see an interesting topping pattern occurring over a ten to fifteen year period that may be further evidence of their inability to meet increasing global demand. What’s most interesting about this chart is that Saudi oil production peaked in 2004 even in the face of a huge run up in oil from $30/barrel to $145/barrel in 2008. Percentage wise, oil gained close to 400% over those 4 years whereas production increased only an approximate 20% in response. That’s just not good business…unless, that’s all you got to give. (more)

Historical Analyses Suggest S&P 500 To Top Out at 1400 – and then topple to 400

Based on a unique comparison with the Nikkei 225 and prior mega-bears it seems evident that the S&P 500 should continue its rise to 1400 or so in the first half of 2011 before it collapses completely down to an unbelievably low of 400. Before you totally reject this possibility please read the entire article.

Bank of America Merrill Lynch Asia’s Comparison With Nikkei 225

Market strategists Sadiq Currimbhoy, Arik Reiss, and Jacky Tang of Bank of America Merrill Lynch Asia identified a pattern back in 2009 that supports the likelihood of additional gains in the S&P 500 regardless of the extent of the extent of the economic recovery in the U.S.. The analysts plotted the S&P 500 in DXY terms against the Nikkei by rebasing the S&P 500 to the same peak as the Nikkei but lagged by 117 months (i.e. 9.75 years) and uncovered an uncanny relationship as shown in the chart below.

Their analysis suggested that the S&P peak would be achieved by December 10th of last year but that obviously was not the case. Failing to achieve such a precise projection can be excused so the realization of such a target in the first half of 2011 should be deemed acceptable. (more)

MoneySense - February/March 2011

read more here

BNN: Top Picks

James Hodgins, Chief Investment Officer, Curvature Hedge Strategies shares his top picks.


click here for video

Ford Motor Co. (F) Stock Analysis

The following is Ford Motor Co . (F) Technical analysis for February 01, 2010

Ford Motor Co F Resistance, pivot & Support Levels - 02/01/2011

Resistance levels: $17.83, $17.20, $16.57

Pivot point: $16.01

Support levels:$15.38, $14.82, $14.19

Share of Ford is trading over $16 today but stock not up a lot need some considerations here that is good for stock. Ford continues to be a strong buy between $15 -$16.Ford stock has been on an nice run last year. Ford will have support level $15.45. Ford continues is a strong buy below low $15 .Ford is a strong buy below $16 if we get a pullback in 2011.This is my long term investment .This is my one top pick for 2011.